GLYBERA Trademark

Trademark Overview


On Friday, April 23, 2010, a trademark application was filed for GLYBERA with the United States Patent and Trademark Office. The USPTO has given the GLYBERA trademark a serial number of 85021985. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 26, 2018. This trademark is owned by Amsterdam Molecular Therapeutics (AMT) IP B.V.. The GLYBERA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy vectors; biological preparations for medical use; biological preparations for medical use, namely, metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, namely, vaccines and prophylaxis products for use in nuclei acid-based therapy, gene therapy and cell therapy; gene and nucleic acid modulation for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy and prophylaxis products, namely, gene delivery and gene transfer for the treatment of metabolic disorders and disorders which are the result of one ...

Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders through gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation
glybera

General Information


Serial Number85021985
Word MarkGLYBERA
Filing DateFriday, April 23, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 26, 2018
Registration Number4113673
Registration DateTuesday, March 20, 2012
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 3, 2012

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "Glybera" with a dot in the letter "G".
Goods and ServicesPharmaceutical preparations and substances for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy vectors; biological preparations for medical use; biological preparations for medical use, namely, metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, namely, vaccines and prophylaxis products for use in nuclei acid-based therapy, gene therapy and cell therapy; gene and nucleic acid modulation for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy and prophylaxis products, namely, gene delivery and gene transfer for the treatment of metabolic disorders and disorders which are the result of one or more mutations within the lipoprotein lipase gene; all the aforementioned goods used exclusively in the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene
Goods and ServicesMedical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders through gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 26, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 26, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUNIQURE IP B.V.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressAMSTERDAM 1105 BA
NL

Party NameAmsterdam Molecular Therapeutics (AMT) IP B.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAmsterdam 61 1105BA
NL

Party NameAmsterdam Molecular Therapeutics (AMT) IP B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAmsterdam 61 1105BA
NL

Party NameAmsterdam Molecular Therapeutics (AMT) IP B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAmsterdam 61 1105BA
NL

Trademark Events


Event DateEvent Description
Friday, October 26, 2018CANCELLED SEC. 8 (6-YR)
Monday, March 20, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 5, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 12, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 20, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, January 3, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 28, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 22, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 22, 2011EXAMINER'S AMENDMENT ENTERED
Monday, November 21, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 21, 2011EXAMINERS AMENDMENT E-MAILED
Monday, November 21, 2011EXAMINERS AMENDMENT -WRITTEN
Friday, November 4, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 4, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 4, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 18, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2011NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2011NON-FINAL ACTION WRITTEN
Wednesday, April 13, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 13, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 13, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 14, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 14, 2011NON-FINAL ACTION E-MAILED
Monday, February 14, 2011NON-FINAL ACTION WRITTEN
Tuesday, January 18, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 18, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 11, 2011ASSIGNED TO LIE
Monday, December 20, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 23, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 23, 2010NON-FINAL ACTION E-MAILED
Wednesday, June 23, 2010NON-FINAL ACTION WRITTEN
Tuesday, June 22, 2010ASSIGNED TO EXAMINER
Thursday, April 29, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, April 28, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 27, 2010NEW APPLICATION ENTERED IN TRAM